Holen Sie sich die Stockscreener-App
9.325
1.47%
0.135
Schlusskurs vom Vortag:
$9.19
Offen:
$9.0968
24-Stunden-Volumen:
4,721
Relative Volume:
0.21
Marktkapitalisierung:
$6.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.05M
KGV:
-4.3372
EPS:
-2.15
Netto-Cashflow:
$-17.78M
1W Leistung:
-10.51%
1M Leistung:
-20.23%
6M Leistung:
-94.18%
1J Leistung:
-92.37%
1-Tages-Spanne:
$8.93
$9.7101
1-Wochen-Bereich:
$8.77
$10.42
52-Wochen-Spanne:
$8.77
$196.70
Envveno Medical Corporation Stock (NVNO) Company Profile
Firmenname
Envveno Medical Corporation
Sektor
Branche
Telefon
949-261-2900
Adresse
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
9.325 | 6.03M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Envveno Medical Corporation Aktie (NVNO) Neueste Nachrichten
enVVeno Medical Announces Reverse Stock Split - The Florida Times-Union
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Lansing State Journal
Strategic Investor Acquires Significant Stake in enVVeno Medical - AD HOC NEWS
Aug Analyst Calls: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO) - Defense World
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - The Northwest Florida Daily News
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - DelmarvaNow.com
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans - The Globe and Mail
EnVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - News Channel Nebraska Southeast
enVVeno Medical regains Nasdaq compliance, reports $28 million cash By Investing.com - Investing.com Nigeria
enVVeno Medical regains compliance with Nasdaq minimum bid price rule - TipRanks
enVVeno Medical Regains Nasdaq Compliance - Orange County Business Journal
enVVeno Medical regains Nasdaq compliance, reports $28 million cash - Investing.com
Bank Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Performance Recap & Smart Investment Allocation Tips - baoquankhu1.vn
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Green Bay Press-Gazette
Breakout Zone: Why is Pliant Therapeutics Inc stock going upJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Volume Report: Will enVVeno Medical Corporation benefit from seasonalityShort Setup & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Highs Report: Is enVVeno Medical Corporation trading at a discount2025 Support & Resistance & Long Hold Capital Preservation Tips - baoquankhu1.vn
enVVeno Medical Executes One-for-35 Reverse Stock Split - TipRanks
EnVVeno Medical announces reverse stock split; shares down 20% - MSN
enVVeno Medical announces RSS - Medical Buyer
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Do Not Use - ocbj.com
enVVeno Medical Stock Set to Reverse Split on Tuesday, January 20th (NASDAQ:NVNO) - Defense World
enVVeno Medical announces 1-for-35 reverse stock split By Investing.com - Investing.com Nigeria
enVVeno Medical Approves 1-for-35 Reverse Stock Split, Reducing Shares to 655K - Intellectia AI
enVVeno Medical announces 1-for-35 reverse stock split - Investing.com
enVVeno Medical board approves 1-for-35 reverse stock split - TipRanks
What enVVeno's 1-for-35 reverse stock split means for shareholders in 2026 - Stock Titan
Midday Stock Roundup: Staar Down 4% on Board Changes - Orange County Business Journal
enVVeno Medical presents efficacy data from SAVVE U.S. trial for VenoValve - TipRanks
Is enVVeno Medical Corporation stock ready for breakout2025 EndofYear Setup & Free Technical Confirmation Trade Alerts - ulpravda.ru
Is enVVeno Medical Corporation stock attractive for hedge fundsTrade Risk Assessment & Daily Risk Controlled Trade Plans - ulpravda.ru
Finanzdaten der Envveno Medical Corporation-Aktie (NVNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):